Originally published as a blog post as part of the Melbourne Writers Festival, 2014
Is AIDS dead? Could we ever ‘end HIV’?
Facilitated by writer Dion Kagan, and featuring long-term AIDS activist Colin Batrouney and epidemiologist Elizabeth Pisani, these were the questions addressed in the provocatively titled session ‘AIDs is Dead! Long Live HIV!’.
But what do these questions actually mean?
It is easy to understand how this has become the case. Effective anti-viral treatment means that contracting HIV is no longer a death sentence – in fact, with the right drugs, you can now live a long life in relative health. This treatment has contributed significantly to the drop in AIDS deaths we’ve seen over the past twenty years. New ‘PREP’ treatments – which could effectively amount to the equivalent of the pill for HIV – are now seen as potentially providing a ‘silver bullet’ for prevention of the disease. As these treatments have become more widely available the public health message has become much more difficult to deliver – we are struggling to convince people that HIV is still an illness you do not want to catch.
As Pisani said, during this session, this is a very good thing! We should be celebrating that effective treatment means we can no longer run the sort of ‘scare campaigns’ that say that if you don’t wear a condom you are going to die. Those campaigns would be patently false today and that is a sign of the success of our movement.
Yet, as this panel pointed out, it also creates a quandary. Despite the progress, the impacts of HIV are still real – whether it is the long-term health risks, the potential side effects from drugs, or the very real threat of the development of drug resistant strains (i.e. strains of HIV that don’t respond to treatment). And that doesn’t even take in to account the costs to our public health system. HIV is still real, and very serious.
Yet, our perception has gone the other way. As AIDS has started to die the story has been seen as completed – leaving those who are living with HIV, and those who at risk of catching it, in many ways left out in the cold.
This is the enduring challenge we are left with. The era of AIDs may be leaving us, but the era of HIV seems – at least for the moment – here to stay. The question is how do we deal with this shift? How do we convince people that the story is not yet over?
This panel didn’t answer these questions – in the short time they had they hardly managed to scrape the surface. But they got us on the right path – they got us asking the right questions. And in this new era of HIV that is exactly what we need.
